Genitourinary Research With Ben Garmezy, MD

Oncology / Hematology

Dr. Garmezy joined Sarah Cannon Research Institute (SCRI) in 2021 and serves as the Associate Director of Genitourinary Research. In his role, Dr. Garmezy oversees investigational therapy trials, as well as standard of care treatments, for GU cancers, including prostate, kidney, bladder, and testicular cancers.